{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:44:25Z","timestamp":1770507865089,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.4065\/77.3.276","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T20:19:36Z","timestamp":1232741976000},"page":"276-282","source":"Crossref","is-referenced-by-count":42,"title":["Evaluation and Treatment of Erectile Dysfunction in Men With Diabetes Mellitus"],"prefix":"10.4065","volume":"77","author":[{"given":"Jayant","family":"Dey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Devin","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/77.3.276_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00251005","article-title":"The prevalence of diabetic impotence","volume":"18","author":"McCulloch","year":"1980","journal-title":"Diabetologia"},{"key":"10.4065\/77.3.276_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF00262216","article-title":"The natural history of impotence in diabetic men","volume":"26","author":"McCulloch","year":"1984","journal-title":"Diabetologia"},{"key":"10.4065\/77.3.276_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2337\/diacare.19.2.135","article-title":"Prevalence of self-reported erectile dysfunction in people with long-term IDDM","volume":"19","author":"Klein","year":"1996","journal-title":"Diabetes Care"},{"key":"10.4065\/77.3.276_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"key":"10.4065\/77.3.276_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.1378650","article-title":"Nitric oxide: a physiologic mediator of penile erection","volume":"257","author":"Burnett","year":"1992","journal-title":"Science"},{"key":"10.4065\/77.3.276_bib6","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1464-410X.1997.00206.x","article-title":"Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro","volume":"79","author":"Jeremy","year":"1997","journal-title":"Br J Urol"},{"key":"10.4065\/77.3.276_bib7","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1056\/NEJM198912143212406","article-title":"Impotence","volume":"321","author":"Krane","year":"1989","journal-title":"N Engl J Med"},{"key":"10.4065\/77.3.276_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0094-0143(05)70133-6","article-title":"Integrative erectile biology: the effects of age and disease on gap junctions and ion channels and their potential value to the treatment of erectile dysfunction","volume":"28","author":"Melman","year":"2001","journal-title":"Urol Clin North Am"},{"key":"10.4065\/77.3.276_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1095\/biolreprod46.3.342","article-title":"Androgen maintenance of erectile function in the rat penis","volume":"46","author":"Mills","year":"1992","journal-title":"Biol Reprod"},{"key":"10.4065\/77.3.276_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF01542116","article-title":"Changes in erectile responsiveness during androgen replacement therapy","volume":"12","author":"Bancroft","year":"1983","journal-title":"Arch Sex Behav"},{"key":"10.4065\/77.3.276_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0090-4295(82)90573-8","article-title":"Vascular factor in erectile failure among diabetics","volume":"19","author":"Jevtich","year":"1982","journal-title":"Urology"},{"key":"10.4065\/77.3.276_bib12","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0022-5347(17)35113-3","article-title":"Erectile dysfunction in diabetic men: the neurological factor revisited","volume":"151","author":"Bemelmans","year":"1994","journal-title":"J Urol"},{"key":"10.4065\/77.3.276_bib13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1464-410X.1995.tb07674.x","article-title":"Diabetes mellitus increases nitric oxide synthase in penises but not in major pelvic ganglia of rats","volume":"76","author":"Elabbady","year":"1995","journal-title":"Br J Urol"},{"key":"10.4065\/77.3.276_bib14","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1210\/en.136.12.5709","article-title":"Reduction in penile nitric oxide synthase in diabetic BB\/WORdp (type I) and BBZ\/WORdp (type II) rats with erectile dysfunction","volume":"136","author":"Vernet","year":"1995","journal-title":"Endocrinology"},{"key":"10.4065\/77.3.276_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1210\/jcem-65-1-127","article-title":"Gonadal dysfunction in diabetic men with organic impotence","volume":"65","author":"Murray","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"5A","key":"10.4065\/77.3.276_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9343(88)90408-1","article-title":"Impotence in diabetic men","volume":"85","author":"Kaiser","year":"1988","journal-title":"Am J Med"},{"key":"10.4065\/77.3.276_bib17","series-title":"Textbook of Erectile Dysfunction","first-page":"497","article-title":"Process of care model for the management of erectile dysfunction in the primary care setting","author":"Rosen","year":"1999"},{"key":"10.4065\/77.3.276_bib18","series-title":"Textbook of Erectile Dysfunction","first-page":"485","article-title":"Shared care management: the primary care perspective","author":"Kirby","year":"1999"},{"key":"10.4065\/77.3.276_bib19","series-title":"Textbook of Erectile Dysfunction","first-page":"141","article-title":"Risk factors for impotence","author":"Lewis","year":"1999"},{"key":"10.4065\/77.3.276_bib20","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction","volume":"338","author":"Goldstein","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/77.3.276_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.281.5.421","article-title":"Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial","volume":"281","author":"Rendell","year":"1999","journal-title":"JAMA"},{"issue":"suppl 1","key":"10.4065\/77.3.276_bib22","first-page":"A90","article-title":"Viagra\u00ae (sildenafil citrate): efficacy and safety in the treatment of erectile dysfunction (ED) in men with diabetes [abstract]","volume":"48","author":"Hirsch","year":"1999","journal-title":"Diabetes"},{"issue":"suppl 1","key":"10.4065\/77.3.276_bib23","first-page":"A35","article-title":"The first study of sildenafil for erectile dysfunction in men with type 2 diabetes mellitus [abstract]","volume":"49","author":"Boulton","year":"2000","journal-title":"Diabetes"},{"key":"10.4065\/77.3.276_bib24","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.1983.03330370046029","article-title":"Impotence in medical clinic outpatients","volume":"249","author":"Slag","year":"1983","journal-title":"JAMA"},{"key":"10.4065\/77.3.276_bib25","series-title":"Andrology in the 21st Century: Proceedings of the VII International Congress of Andrology","first-page":"209","article-title":"The calculation of bioavailable testosterone","author":"Haren","year":"2001"},{"key":"10.4065\/77.3.276_bib26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1464-5491.1986.tb00800.x","article-title":"A pragmatic approach to sexual dysfunction in diabetic men: psychosexual counselling","volume":"3","author":"McCulloch","year":"1986","journal-title":"Diabet Med"},{"issue":"suppl 1","key":"10.4065\/77.3.276_bib27","first-page":"A88","article-title":"Sildenafil citrate for treatment of erectile dysfunction is similarly effective in men with type 1 or type 2 diabetes mellitus [abstract]","volume":"49","author":"Blonde","year":"2000","journal-title":"Diabetes"},{"issue":"suppl 1","key":"10.4065\/77.3.276_bib28","first-page":"A90","article-title":"Safety and tolerability of sildenafil citrate for treatment of erectile dysfunction in men with type 1 and type 2 diabetes mellitus [abstract]","volume":"49","author":"Guay","year":"2000","journal-title":"Diabetes"},{"key":"10.4065\/77.3.276_bib29","author":"Food and Drug Administration Web site"},{"key":"10.4065\/77.3.276_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0735-1097(98)00656-1","article-title":"Use of sildenafil (Viagra) in patients with cardiovascular disease [published correction appears in J Am Coll Cardiol. 1999;34:1850]","volume":"33","author":"Cheitlin","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.4065\/77.3.276_bib31","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1464-5491.1991.tb01538.x","article-title":"The management of impotence in diabetic men by vacuum tumescence therapy","volume":"8","author":"Price","year":"1991","journal-title":"Diabet Med"},{"key":"10.4065\/77.3.276_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/bmj.296.6616.161","article-title":"Successful non-invasive management of erectile impotence in diabetic men","volume":"296","author":"Wiles","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.4065\/77.3.276_bib33","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1464-5491.1994.tb00295.x","article-title":"Treatment of male erectile dysfunction using the active vacuum assist device","volume":"11","author":"Bodansky","year":"1994","journal-title":"Diabet Med"},{"key":"10.4065\/77.3.276_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0090-4295(92)90270-7","article-title":"Twelve-month comparison of two treatments for erectile dysfunction: self-injection versus external vacuum devices","volume":"39","author":"Turner","year":"1992","journal-title":"Urology"},{"key":"10.4065\/77.3.276_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199701023360101","article-title":"Treatment of men with erectile dysfunction with transurethral alprostadil","volume":"336","author":"Padma-Nathan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.4065\/77.3.276_bib36","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0022-5347(01)66315-8","article-title":"The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience","volume":"155","author":"Porst","year":"1996","journal-title":"J Urol"},{"key":"10.4065\/77.3.276_bib37","first-page":"34","article-title":"Salvage of sildenafil non-responder: the role of locally delivered therapies","volume":"2","author":"Kuan","year":"2001","journal-title":"Sex Dysfunct Med"},{"key":"10.4065\/77.3.276_bib38","first-page":"81","article-title":"Intracavernous self-injection pharmacotherapy program: analysis of results and complications","volume":"6","author":"Valdevenito","year":"1994","journal-title":"Int J Impot Res"},{"key":"10.4065\/77.3.276_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0022-5347(01)64032-1","article-title":"Therapeutic effects of high dose yohimbine hydrochloride on organic erectile dysfunction","volume":"159","author":"Teloken","year":"1998","journal-title":"J Urol"},{"key":"10.4065\/77.3.276_bib40","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0022-5347(01)63559-6","article-title":"Oral phentolamine as treatment for erectile dysfunction","volume":"159","author":"Becker","year":"1998","journal-title":"J Urol"},{"key":"10.4065\/77.3.276_bib41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.ijir.3900272","article-title":"Trazodone, a double blind trial for treatment of erectile dysfunction","volume":"9","author":"Meinhardt","year":"1997","journal-title":"Int J Impot Res"},{"key":"10.4065\/77.3.276_bib42","series-title":"Diagnosis and Management of Male Sexual Dysfunction","first-page":"218","article-title":"Overview of penile implants","author":"Mulcahy","year":"1997"},{"key":"10.4065\/77.3.276_bib43","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.320.7243.1165","article-title":"Cost utility analysis of sildenafil compared with papaverine-phentolamine injections","volume":"320","author":"Stolk","year":"2000","journal-title":"BMJ"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611623604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611623604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T09:57:47Z","timestamp":1558087067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611623604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S0025619611623604"],"URL":"https:\/\/doi.org\/10.4065\/77.3.276","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}